
Free
About
Access to Intas B2B portfolio Global-Dossiers: Biosimilars, Added Value Medicines and Generics.
Access to visual overviews on regulatory information and launch landscape.
Search through our portfolio using filters as stability clime zone, jurisdiction, therapeutic area and more.
Always updated with our last developments, filing plan and available MAs.
Show more
What's New in Intas B2B Dossier e
5.0.8
May 4, 2026
Minor improvements and fixes


